- Full Text
- Scholarly Journal
Encouraging the prescribing of SGLT2i and GLP-1RA medications to reduce cardiovascular and renal risk in patients with type 2 diabetes: Rationale and design of a randomized controlled trial
PDF
CiteCite
Copy URL
https://www.proquest.com/scholarly-journals/encouraging-prescribing-sglt2i-glp-1ra/docview/3187159782/se-2?accountid=208611
PrintAll Options